Align methylmalonate-semialdehyde dehydrogenase (CoA-acylating) (EC 1.2.1.27) (characterized)
to candidate WP_034271366.1 AMYHA_RS13060 5-carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenase
Query= BRENDA::P42412 (487 letters) >NCBI__GCF_000504245.1:WP_034271366.1 Length = 500 Score = 242 bits (618), Expect = 2e-68 Identities = 149/478 (31%), Positives = 243/478 (50%), Gaps = 11/478 (2%) Query: 5 RKLKNYINGEWVESKTDQYEDVVNPATKEVLCQVPISTKEDIDYAAQTAAEAFK--TWSK 62 +++ +YI+GE V+S + DV++P + + DID A A EAF W + Sbjct: 9 QRISHYIDGEHVDSISGDTFDVLDPVSNKPYATAAAGHAADIDRAVAAAREAFTDGAWPR 68 Query: 63 VAVPRRARILFNFQQLLSQHKEELAHLITIENGKNTKEALGEVGRGIENVEFAAGAPSLM 122 + RAR+L+ + ++ LA L + + G +A G+ R EN F A M Sbjct: 69 MKARERARVLYRVADAVEAAEDRLAELESFDTGLPITQAKGQARRAAENFRFFADLIVAM 128 Query: 123 MGDSLASIATDVEAANY--RYPIGVVGGIAPFNFPMMVPCWMFPMAIALGNTFILKPSER 180 D+ + T + NY R P+GV G I P+N P M+ W A+A G +LKP+E Sbjct: 129 NEDAYSVPGTQL---NYVLRKPVGVAGLITPWNTPFMLESWKLAPALAAGCPVVLKPAEF 185 Query: 181 TPLLTEKLVELFEKAGLPKGVFNVVYGAHDVVN-GILEHPEIKAISFVGSKPVGEYVYKK 239 TP +FE AGLP+GVFN+V G + ++EHP++ ISF G G+ + + Sbjct: 186 TPASASLWAGIFEAAGLPRGVFNLVNGIGEQAGQALVEHPDVPLISFTGETTTGQTIMRS 245 Query: 240 GSENLKRVQSLTGAKNHTIVLNDANLEDTVTNIVGAAFGSAGERCMACAVVTVEEGIADE 299 + +LK + G K+ IV DA+L+ + + + F GERC A + + V+ I +E Sbjct: 246 AAAHLKELSMELGGKSPAIVFADADLDAAIDSTLFGVFSLNGERCTAGSRILVQRAIYEE 305 Query: 300 FMAKLQEKVADIKIGNGLDDGVFLGPVIREDNKKRTLSYIEKGLEEGARLVCDGRENVSD 359 F + E+ +DI +G D +G ++ ++ +R L Y+E G E L GR + Sbjct: 306 FCGRYAERASDIVVGPPHDPATEVGALVHPEHYERVLGYVEAGKREARLLAGGGRPHHLP 365 Query: 360 DGYFVGPTIFDNVTTEMTIWKDEIFAPVLSVIRVKNLKEAIEIANKSEFANGACLFTSNS 419 +G ++ PT+F +V + TI++ EIF PV ++ EAI +AN ++ ++T++ Sbjct: 366 EGNYLAPTVFADVAPDATIFQQEIFGPVAALTPFDTDDEAIALANDVKYGLAGYVWTNDL 425 Query: 420 NAIRYFRENIDAGMLGINLGVPAPMAFFPFSGWKSSFFGTLHANGKDSVDFYTRKKVV 477 + +I+AGM+ +N + PF G K+S G H G S+DFYT + +V Sbjct: 426 HRGHRVAGSIEAGMVWLNSHNIRDLR-TPFGGVKAS--GVGHEGGHRSIDFYTNEHIV 480 Lambda K H 0.318 0.136 0.396 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 566 Number of extensions: 29 Number of successful extensions: 5 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 487 Length of database: 500 Length adjustment: 34 Effective length of query: 453 Effective length of database: 466 Effective search space: 211098 Effective search space used: 211098 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 52 (24.6 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory